Featured Companies
The Excellence Awards celebrate the greatest achievements and innovations in the industry. The programme provides a platform to recognise the people and companies that are driving change.
Our programme is designed to highlight excellence within the sector by looking at a range of corporate activities including deals, business projects and company initiatives, both internal and in the community.
Has your company won an Excellence Award?
Search to find out if your company is a winner
Is your company listed?
If you want to learn more about the Awards and the range of marketing materials and options available to promote your achievement then please get in touch with us or download the Media Pack:
Contact: Tina Ross – tina.ross@globaldata.com
Or book a meeting direct – https://calendly.com/tina-ross
What is Social?
The Social category includes companies and institutions that have undertaken projects that have had a tangible positive impact on the communities where they operate. This can include anything from charity initiatives; sponsorship; community outreach; local business support and education initiatives.
Themes
In light of the COVID pandemic, providing access to diagnostic devices has been a top priority among the more socially responsible companies in the medical devices industry.
Vaccine availability too has also been an issue in low and middle income countries with many companies trying to improve the transportation process of mRNA vaccines to tackle the issue. The efforts of Chinese company Recbio are particularly notable in this regard.
Various programmes have also been established in order to combat health inequity by both public and private entities. The US government in particular has been buying up COVID technologies and making them available to developing countries.
Categories
The category includes companies and public institutions that have made contributions to healthcare access during the research period.
The category highlights companies and public institutions that have made contributions to vaccine coverage during the research period.
